Ah. Fahal et al., GASTROINTESTINAL-TRACT CANCER IN ASSOCIATION WITH HEPATITIS AND HIV-INFECTION, East African medical journal, 72(7), 1995, pp. 424-426
One hundred and fifty patients with histologically proven gastrointest
inal tract (GIT) cancer, 150 patients with a variety of other malignan
cies and 150 normal subjects were screened for human immunodeficiency
virus (HIV) and hepatitis B sere-markers. Only one patient with nasoph
aryngeal carcinoma proved to he HIV seropositive. Hepatitis B surface
antigen (ESBsAg) was detected in 18% (n = 26) of the GIT cancer patien
ts, in 16% (n = 24) of the other cancers group and in 12% (n = 20) of
the control. There was no significant difference between the three gro
ups (P > 0.1). The HBsAg was detected mainly in patients with primary
hepatocelluar (25%), gastric (12%), rectal (10%) and colonic carcinoma
(8%). Hepatitis B core antibody (HBc AB) was detected in 12% of the G
IT cancer patients, in 11% of the other cancers patients and in 13% of
the control. In this study, there was no association between HIV, hep
atitis BI infections and GIT cancer.